Literature DB >> 21556760

The Ku70 -1310C/G promoter polymorphism is associated with breast cancer susceptibility in Chinese Han population.

Wenshan He1, Sijia Luo, Tao Huang, Jinghua Ren, Xiaoling Wu, Jun Shao, Qingyao Zhu.   

Abstract

Ku70 plays an important role in the DSBR (DNA double-strand breaks repair) and maintenance of genomic integrity. Genetic variations within human Ku70 have been demonstrated to be associated with increased risk of several types of cancers. In this hospital-based case-control study, we aimed to investigate whether a single nucleotide polymorphism (SNP) in the promoter region (rs2267437) of Ku70 gene is associated with susceptibility to breast cancer in Chinese Han population. A total of 293 patients with breast cancer and 301 age-matched healthy controls were enrolled in this study. The Ku70 -1310C/G polymorphism was determined by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. A significant difference in genotype distribution and allele frequency was observed between patients and controls. The CG or GG carries were at higher risk of breast cancer compared with the CC homozygotes (OR=1.43, 95% CI=1.02-2.00, P=0.038 and OR=3.53, 95% CI=1.60-7.80, P=0.002, respectively). Further stratification analysis revealed that G allele was associated with an increased risk of breast cancer among premenopausal women (OR=1.68, 95% CI=1.21-2.33, P=0.002), but not in postmenopausal women (OR=1.33, 5% CI=0.85-2.10, P=0.216). Our study suggests that the Ku70 -1310C/G promoter polymorphism may be a susceptibility factor for breast cancer in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21556760     DOI: 10.1007/s11033-011-0773-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  35 in total

1.  Association between polymorphisms of XRCC1 and offspring sex ratio at births in families of female breast cancer patients.

Authors:  Mostafa Saadat; Iraj Saadat
Journal:  Breast Cancer Res Treat       Date:  2009-08-22       Impact factor: 4.872

2.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 3.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

4.  Effects of reproductive and demographic changes on breast cancer incidence in China: a modeling analysis.

Authors:  Eleni Linos; Demetri Spanos; Bernard A Rosner; Katerina Linos; Therese Hesketh; Jian Ding Qu; Yu-Tang Gao; Wei Zheng; Graham A Colditz
Journal:  J Natl Cancer Inst       Date:  2008-09-23       Impact factor: 13.506

5.  Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1.

Authors:  Da-Tian Bau; Yi-Ping Fu; Shou-Tung Chen; Ting-Chih Cheng; Jyh-Cherng Yu; Pei-Ei Wu; Chen-Yang Shen
Journal:  Cancer Res       Date:  2004-07-15       Impact factor: 12.701

6.  Single-nucleotide polymorphisms in DNA double-strand break repair genes: association with head and neck cancer and interaction with tobacco use and alcohol consumption.

Authors:  Joke Werbrouck; Kim De Ruyck; Fréderic Duprez; Marc Van Eijkeren; Ernst Rietzschel; Sofie Bekaert; Anne Vral; Wilfried De Neve; Hubert Thierens
Journal:  Mutat Res       Date:  2008-08-13       Impact factor: 2.433

7.  Association of XPD polymorphisms with severe toxicity in non-small cell lung cancer patients in a Chinese population.

Authors:  Wenting Wu; Wei Zhang; Rong Qiao; Dan Chen; Huibo Wang; Yi Wang; Shuyu Zhang; Ge Gao; Aiqin Gu; Jie Shen; Ji Qian; Weiwei Fan; Li Jin; Baohui Han; Daru Lu
Journal:  Clin Cancer Res       Date:  2009-05-19       Impact factor: 12.531

8.  DNA repair gene polymorphisms predict favorable clinical outcome in advanced non-small-cell lung cancer.

Authors:  Aristea Kalikaki; Maria Kanaki; Helen Vassalou; John Souglakos; Alexandra Voutsina; Vassilis Georgoulias; Dimitris Mavroudis
Journal:  Clin Lung Cancer       Date:  2009-03       Impact factor: 4.785

Review 9.  Platinum resistance: the role of DNA repair pathways.

Authors:  Lainie P Martin; Thomas C Hamilton; Russell J Schilder
Journal:  Clin Cancer Res       Date:  2008-03-01       Impact factor: 12.531

Review 10.  The changing global patterns of female breast cancer incidence and mortality.

Authors:  Freddie Bray; Peter McCarron; D Maxwell Parkin
Journal:  Breast Cancer Res       Date:  2004-08-26       Impact factor: 6.466

View more
  7 in total

1.  Quantitative assessment of the association between XRCC6 C1310G polymorphism and cancer risk.

Authors:  Hong Jiang; Yun Lin; Chang-qing Yang; Qi Li; Jinhong Luo; Ying Zhou; Junli Xue; Wei Wei; Yong Gao
Journal:  Tumour Biol       Date:  2012-12-28

Review 2.  Association between the XRCC6 Promoter rs2267437 polymorphism and cancer risk: evidence based on the current literature.

Authors:  Haitao Xu; Peng Zou; Pin Chen; Lin Zhao; Peng Zhao; Ailin Lu
Journal:  Genet Test Mol Biomarkers       Date:  2013-06-08

3.  Role of polymorphic XRCC6 (Ku70)/XRCC7 (DNA-PKcs) genes towards susceptibility and prognosis of lung cancer patients undergoing platinum based doublet chemotherapy.

Authors:  Amrita Singh; Navneet Singh; Digambar Behera; Siddharth Sharma
Journal:  Mol Biol Rep       Date:  2018-02-03       Impact factor: 2.316

Review 4.  Association between the XRCC6 polymorphisms and cancer risks: a systematic review and meta-analysis.

Authors:  Jing Jia; Juan Ren; Dongmei Yan; Long Xiao; Ruifen Sun
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 5.  The Role of the Core Non-Homologous End Joining Factors in Carcinogenesis and Cancer.

Authors:  Brock J Sishc; Anthony J Davis
Journal:  Cancers (Basel)       Date:  2017-07-06       Impact factor: 6.639

6.  Architecture of The Human Ape1 Interactome Defines Novel Cancers Signatures.

Authors:  Dilara Ayyildiz; Giulia Antoniali; Chiara D'Ambrosio; Giovanna Mangiapane; Emiliano Dalla; Andrea Scaloni; Gianluca Tell; Silvano Piazza
Journal:  Sci Rep       Date:  2020-01-08       Impact factor: 4.379

7.  XRCC5/6 polymorphisms and their interactions with smoking, alcohol consumption, and sleep satisfaction in breast cancer risk: A Chinese multi-center study.

Authors:  Li-Xiang Yu; Li-Yuan Liu; Yu-Juan Xiang; Fei Wang; Fei Zhou; Shu-Ya Huang; Chao Zheng; Chun-Miao Ye; Wen-Zhong Zhou; Geng-Shen Yin; Jia-Lin Zhang; Shu-De Cui; Fu-Guo Tian; Zhi-Min Fan; Cui-Zhi Geng; Xu-Chen Cao; Zhen-Lin Yang; Xiang Wang; Hong Liang; Shu Wang; Hong-Chuan Jiang; Xue-Ning Duan; Hai-Bo Wang; Guo-Lou Li; Qi-Tang Wang; Jian-Guo Zhang; Feng Jin; Jin-Hai Tang; Liang Li; Shi-Guang Zhu; Wen-Shu Zuo; Zhong-Bing Ma; Zhi-Gang Yu
Journal:  Cancer Med       Date:  2021-03-18       Impact factor: 4.452

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.